Biotech

All Articles

Lykos will ask FDA to reassess its own choice complying with being rejected of MDMA treatment for trauma

.Observing a bad revealing for Lykos Therapeutics' MDMA candidate for post-traumatic stress disorder...

AN 2 one-halfs census, stops phase 3 test after information dissatisfy

.AN2 Therapies is reconsidering its business in feedback to poor midphase records, vowing to lay off...

Merck pays $700M for bispecific, spying autoimmune opening and also possibility to test Amgen in cancer

.Merck &amp Co. is actually paying out $700 thousand in advance to test Amgen in a blood stream canc...

Gilead pays for J&ampJ $320M to go out licensing offer for seladelpar

.With Gilead Sciences about to an FDA choice for its liver health condition medicine seladelpar, the...

' All hands on deck' at Lilly as peers target obesity market

.CEO David Ricks may see the providers establishing outdoors tents at basecamp behind Eli Lilly in a...

Entero giving up team, vacating workplace as well as stopping briefly R&ampD

.Bed Liquidators has turned Entero Therapies white colored as a piece. The financial institution pur...

Exelixis loses ADC after deciding it's no match for Tivdak

.Exelixis is actually surrendering on its own cells factor (TF)- targeting antibody-drug conjugate a...

Relay loses interest in SHP2 inhibitor after Genentech leaves behind

.3 full weeks after Roche's Genentech device left an SHP2 inhibitor treaty, Relay Rehab has affirmed...

Stoke's Dravet disorder med launched of predisposed scientific grip

.Stoke Therapies' Dravet syndrome medicine has actually been without a predisposed hold, clearing th...

Fierce Biotech's Gabrielle Masson provides Intense 15 at NYSE

.Ferocious Biotech Associate Publisher Gabrielle Masson offered the 2024 lesson of Fierce 15 champio...